Header Logo

Connection

PETER JINDRA to Alemtuzumab

Back to Details
This is a "connection" page, showing publications PETER JINDRA has written about Alemtuzumab.
PETER JINDRA
Connection Strength
0.026
Alemtuzumab
  1. Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2014 Mar; 49(3):389-96.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.